These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26444460)

  • 1. Specialty Pharmaceuticals for Hyperlipidemia--Impact on Insurance Premiums.
    Schulman KA; Balu S; Reed SD
    N Engl J Med; 2015 Oct; 373(17):1591-3. PubMed ID: 26444460
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs.
    Everett BM; Smith RJ; Hiatt WR
    N Engl J Med; 2015 Oct; 373(17):1588-91. PubMed ID: 26444323
    [No Abstract]   [Full Text] [Related]  

  • 3. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value.
    Tice JA; Kazi DS; Pearson SD
    JAMA Intern Med; 2016 Jan; 176(1):107-8. PubMed ID: 26662572
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipidemia. New treatment option with Evolocumab].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2014 Jul; 37(7):271-2. PubMed ID: 25065173
    [No Abstract]   [Full Text] [Related]  

  • 5. New class PCSK9 blockers stride into cholesterol market.
    Sheridan C
    Nat Biotechnol; 2015 Aug; 33(8):785-6. PubMed ID: 26252118
    [No Abstract]   [Full Text] [Related]  

  • 6. Alirocumab (Praluent) to lower LDL-Cholesterol.
    Med Lett Drugs Ther; 2015 Aug; 57(1475):113-5. PubMed ID: 26262881
    [No Abstract]   [Full Text] [Related]  

  • 7. Finding the Right Price for Improving Care.
    Charlton B
    JAMA Intern Med; 2016 Jan; 176(1):109. PubMed ID: 26662340
    [No Abstract]   [Full Text] [Related]  

  • 8. Update of Clinical Trials of Anti-PCSK9 Antibodies.
    Wu NQ; Li S; Li JJ
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):159-69. PubMed ID: 25916406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy and clinical trials.
    Sodhi N; Krasuski RA
    Curr Opin Lipidol; 2013 Jun; 24(3):281-2. PubMed ID: 23652475
    [No Abstract]   [Full Text] [Related]  

  • 10. New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.
    Shrank WH; Barlow JF; Brennan TA
    JAMA; 2015 Oct; 314(14):1443-4. PubMed ID: 26258765
    [No Abstract]   [Full Text] [Related]  

  • 11. PCSK9 Inhibitors May Show Benefits of Ultra-Low LDL Levels.
    Reinke T
    Manag Care; 2015 Aug; 24(8):13-4. PubMed ID: 26399135
    [No Abstract]   [Full Text] [Related]  

  • 12. Revisiting Outcomes-Based Pricing Propositions for the PCSK9 Inhibitor Evolocumab.
    Hernandez I
    JAMA Intern Med; 2017 Sep; 177(9):1388-1390. PubMed ID: 28783812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PCSK9 inhibitors: new treatment to lower cholesterol].
    Gencer B; Rodondi N; Mach F
    Rev Med Suisse; 2016 Mar; 12(508):440-2, 444. PubMed ID: 27089600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Into the future: diversifying lipid management.
    Tonkin AM; Watts GF
    Lancet; 2012 Dec; 380(9858):1971-4. PubMed ID: 23141810
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibodies in addition to statin therapy lowers LDL cholesterol].
    Bossenmayer S
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1728. PubMed ID: 23281534
    [No Abstract]   [Full Text] [Related]  

  • 16. Winner by points?--LDL cholesterol as a target for therapeutic intervention.
    Tietge UJ
    Curr Opin Lipidol; 2013 Jun; 24(3):277-8. PubMed ID: 23652473
    [No Abstract]   [Full Text] [Related]  

  • 17. PCSK9 inhibitors are go.
    Mullard A
    Nat Rev Drug Discov; 2015 Sep; 14(9):593. PubMed ID: 26323538
    [No Abstract]   [Full Text] [Related]  

  • 18. PCSK9 Inhibitors: A Technology Worth Paying For?
    Weintraub WS; Gidding SS
    Pharmacoeconomics; 2016 Mar; 34(3):217-20. PubMed ID: 26689785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics inch toward cholesterol-lowering market.
    Garber K
    Nat Biotechnol; 2012 Apr; 30(4):302-4. PubMed ID: 22491269
    [No Abstract]   [Full Text] [Related]  

  • 20. PCSK9 inhibitors on the way.
    Patel KR
    Manag Care; 2014 Nov; 23(11):43. PubMed ID: 25939173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.